XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.3
OTHER (INCOME)/EXPENSE, NET - Schedule of Other Income Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Alliance Statement [Line Items]        
Interest expense (Note 10) $ 505 $ 280 $ 1,451 $ 850
Royalty and licensing income (Note 4) (180) (365) (532) (1,068)
Royalty income - divestiture (Note 4) (284) (217) (820) (623)
Investment income (94) (107) (364) (304)
Litigation and other settlements (a) 0 (61) 71 (393)
Provision for restructuring (Note 6) 78 141 558 321
Integration expenses 69 54 214 180
Equity investment (gains)/losses (Note 9) (12) 0 (221) 213
Acquisition expense (Note 4) 0 0 50 0
Intangible asset impairment 47 89 917 109
Other(b) 105 (12) 134 8
Other (income)/expense, net 234 (258) 588 (787)
Pension settlement charges 100   119  
Other (income)/expense, net        
Alliance Statement [Line Items]        
Intangible asset impairment $ 47 $ 29 47 29
Nimbus Therapuetics TYK2 Inhibitor        
Alliance Statement [Line Items]        
Proceeds from legal settlements       $ 400
Eisai        
Alliance Statement [Line Items]        
Income related to collaboration termination     $ 90